AI Science Tracker

Claude designs protein binders for 15 targets

Anthropic · 18 Aug 2026 · biology

Discovery

Anthropic

Claude designs protein binders for 15 targets

After an initial prompt, Claude selected binding sites, used design and folding models, and chose candidates, with success on 14 of 15 targets. Of 1,320 designs, 354 bound, for rates of 22–35% versus a typical 10–15%. None of the 90 designs for the maltose-binding protein worked. External labs ran the tests.

Technology: Claude (Mythos Preview and Opus 4.8)

Family Claude: profile · models page

Publication: Announcement only · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Announcement only
  • Test type: direct test
  • Tested: External labs (Adaptyv Bio and Twist Bioscience) produced and tested the designs: 354 of 1,320 designs bound, with hit rates of 22-35% versus a typical 10-15%; none of 90 designs for maltose-binding protein bound. The collaborating external laboratories performed candidate production and binding assays within the discovery project; separate independent follow-up replication is not established by this account.
  • Still unknown: Anthropic plans further characterization to confirm hit rates and affinities; BBF-14 affinities are modest, GDF-8 data were inconclusive and excluded, and the TNFa result is unexplained.
  • AI role: Claude chose binding sites, generated candidate structures and sequences by orchestrating structure, sequence and co-folding models, ran in silico optimization and chose candidates.

Evidence sources: https://www.anthropic.com/research/Claude-accelerates-protein-design

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: blog. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.